vs
BK Technologies Corp（BKTI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是BK Technologies Corp的1.7倍（$35.5M vs $21.5M），BK Technologies Corp净利率更高（19.7% vs -304.2%，领先323.9%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 20.0%），BK Technologies Corp自由现金流更多（$2.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -21.6%）
BK Technologies Corp主要设计、生产和销售模拟及数字双向无线电通信设备及相关配件，核心产品服务于公共安全部门、应急响应人员、政府机构及北美地区商业客户，专注于提供高可靠性的关键任务通信解决方案。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BKTI vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.5M | $35.5M |
| 净利润 | $4.2M | $-108.1M |
| 毛利率 | 50.5% | 59.8% |
| 营业利润率 | 19.7% | -304.8% |
| 净利率 | 19.7% | -304.2% |
| 营收同比 | 20.0% | 681.7% |
| 净利润同比 | 15.6% | 39.6% |
| 每股收益（稀释后） | $1.06 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $21.5M | $35.5M | ||
| Q3 25 | $24.4M | $5.2M | ||
| Q2 25 | $21.2M | $19.2M | ||
| Q1 25 | $19.1M | $14.7M | ||
| Q4 24 | $17.9M | $4.5M | ||
| Q3 24 | $20.2M | $26.1M | ||
| Q2 24 | $20.3M | $14.4M | ||
| Q1 24 | — | $13.8M |
| Q4 25 | $4.2M | $-108.1M | ||
| Q3 25 | $3.4M | $-162.3M | ||
| Q2 25 | $3.7M | $-171.9M | ||
| Q1 25 | $2.1M | $-202.5M | ||
| Q4 24 | $3.7M | $-178.9M | ||
| Q3 24 | $2.4M | $-95.8M | ||
| Q2 24 | $1.7M | $-97.5M | ||
| Q1 24 | — | $-91.4M |
| Q4 25 | 50.5% | 59.8% | ||
| Q3 25 | 49.9% | -183.8% | ||
| Q2 25 | 47.4% | -4.9% | ||
| Q1 25 | 47.0% | -48.0% | ||
| Q4 24 | 41.2% | -181.4% | ||
| Q3 24 | 38.8% | 53.7% | ||
| Q2 24 | 37.3% | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 19.7% | -304.8% | ||
| Q3 25 | 19.8% | -3327.6% | ||
| Q2 25 | 18.9% | -916.8% | ||
| Q1 25 | 15.3% | -1297.9% | ||
| Q4 24 | 12.3% | -4042.4% | ||
| Q3 24 | 12.9% | -377.1% | ||
| Q2 24 | 10.0% | -697.4% | ||
| Q1 24 | — | -698.4% |
| Q4 25 | 19.7% | -304.2% | ||
| Q3 25 | 14.1% | -3135.3% | ||
| Q2 25 | 17.7% | -894.2% | ||
| Q1 25 | 11.2% | -1373.3% | ||
| Q4 24 | 20.4% | -3935.5% | ||
| Q3 24 | 11.7% | -367.5% | ||
| Q2 24 | 8.2% | -676.6% | ||
| Q1 24 | — | -662.4% |
| Q4 25 | $1.06 | $-0.17 | ||
| Q3 25 | $0.87 | $-0.36 | ||
| Q2 25 | $0.96 | $-0.41 | ||
| Q1 25 | $0.55 | $-0.50 | ||
| Q4 24 | $0.96 | $-0.56 | ||
| Q3 24 | $0.63 | $-0.34 | ||
| Q2 24 | $0.47 | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.8M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $44.7M | $1.1B |
| 总资产 | $63.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $22.8M | $743.3M | ||
| Q3 25 | $21.5M | $659.8M | ||
| Q2 25 | $11.9M | $525.1M | ||
| Q1 25 | $8.9M | $500.5M | ||
| Q4 24 | $7.1M | $594.4M | ||
| Q3 24 | $4.2M | $427.6M | ||
| Q2 24 | $3.0M | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $44.7M | $1.1B | ||
| Q3 25 | $41.0M | $1.0B | ||
| Q2 25 | $36.8M | $919.1M | ||
| Q1 25 | $32.4M | $933.9M | ||
| Q4 24 | $29.8M | $1.0B | ||
| Q3 24 | $26.0M | $524.6M | ||
| Q2 24 | $23.4M | $584.4M | ||
| Q1 24 | — | $401.2M |
| Q4 25 | $63.8M | $1.5B | ||
| Q3 25 | $66.9M | $1.4B | ||
| Q2 25 | $60.4M | $1.3B | ||
| Q1 25 | $56.1M | $1.3B | ||
| Q4 24 | $51.5M | $1.4B | ||
| Q3 24 | $46.4M | $726.5M | ||
| Q2 24 | $48.9M | $775.9M | ||
| Q1 24 | — | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $2.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | 13.2% | -133.1% |
| 资本支出强度资本支出/营收 | 0.7% | 3.5% |
| 现金转化率经营现金流/净利润 | 0.71× | — |
| 过去12个月自由现金流最近4个季度 | $18.4M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $3.0M | $-46.1M | ||
| Q3 25 | $10.4M | $-117.4M | ||
| Q2 25 | $3.9M | $-76.4M | ||
| Q1 25 | $2.1M | $-132.0M | ||
| Q4 24 | $3.8M | $-115.4M | ||
| Q3 24 | $5.7M | $-59.2M | ||
| Q2 24 | $4.1M | $-82.2M | ||
| Q1 24 | — | $-102.3M |
| Q4 25 | $2.8M | $-47.3M | ||
| Q3 25 | $10.1M | $-117.6M | ||
| Q2 25 | $3.7M | $-79.6M | ||
| Q1 25 | $1.8M | $-133.8M | ||
| Q4 24 | $3.4M | $-116.7M | ||
| Q3 24 | $5.2M | $-63.8M | ||
| Q2 24 | $3.9M | $-83.4M | ||
| Q1 24 | — | $-109.0M |
| Q4 25 | 13.2% | -133.1% | ||
| Q3 25 | 41.3% | -2272.5% | ||
| Q2 25 | 17.3% | -413.9% | ||
| Q1 25 | 9.6% | -907.4% | ||
| Q4 24 | 19.2% | -2567.7% | ||
| Q3 24 | 25.8% | -244.6% | ||
| Q2 24 | 19.2% | -578.5% | ||
| Q1 24 | — | -789.9% |
| Q4 25 | 0.7% | 3.5% | ||
| Q3 25 | 1.5% | 4.7% | ||
| Q2 25 | 1.2% | 16.4% | ||
| Q1 25 | 1.4% | 12.4% | ||
| Q4 24 | 2.0% | 28.6% | ||
| Q3 24 | 2.2% | 17.5% | ||
| Q2 24 | 1.0% | 8.2% | ||
| Q1 24 | — | 48.2% |
| Q4 25 | 0.71× | — | ||
| Q3 25 | 3.04× | — | ||
| Q2 25 | 1.04× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 2.40× | — | ||
| Q2 24 | 2.46× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
